Abstract:Human growth hormone (hGH) plays critical roles in pubertal mammary gland growth, development, and sexual maturation. Accumulated studies have reported that autocrine/paracrine hGH is an orthotopically expressed oncoprotein that promotes normal mammary epithelial cell oncogenic transformation. Autocrine/paracrine hGH has also been reported to promote mammary epithelial cell epithelial-mesenchymal transition (EMT) and invasion. However, the underlying mechanism remains largely obscure. MicroRNAs (miRNAs) are reported to be involved in regulation of multiple cellular functions of cancer. To determine whether autocrine/paracrine hGH promotes EMT and invasion through modulation of miRNA expression, we performed microarray profiling using MCF-7 cells stably expressing wild type or a translation-deficient hGH gene and identified miR-96-182-183 as an autocrine/paracrine hGH-regulated miRNA cluster. Forced expression of miR-96-182-183 conferred on epithelioid MCF-7 cells a mesenchymal phenotype and promoted invasive behavior in vitro and dissemination in vivo. Moreover, we observed that miR-96-182-183 promoted EMT and invasion by directly and simultaneously suppressing BRMS1L (breast cancer metastasis suppressor 1-like) gene expression. miR-96 and miR-182 also targeted GHR, providing a potential negative feedback loop in the hGH-GHR signaling pathway. We further demonstrated that autocrine/paracrine hGH stimulated miR-96-182-183 expression and facilitated EMT and invasion via STAT3 and STAT5 signaling. Consistent with elevated expression of autocrine/paracrine hGH in metastatic breast cancer tissue, miR-96-182-183 expression was also remarkably enhanced. Hence, we delineate the roles of the miRNA-96-182-183 cluster and elucidate a novel hGH-GHR-STAT3/STAT5-miR-96-182-183-BRMS1L-ZEB1/E47-EMT/ invasion axis, which provides further understanding of the mechanism of autocrine/paracrine hGH-stimulated EMT and invasion in breast cancer.

The Oncogenic Potential of Growth Hormone

Growth Hormone and Cancer: an Update on Progress

The Contribution of Growth Hormone to Mammary Neoplasia

Potential biomarkers and lncRNA-mRNA regulatory networks in invasive growth hormone-secreting pituitary adenomas

Tumour-Derived Human Growth Hormone As a Therapeutic Target in Oncology.

Autocrine/paracrine Growth Hormone in Cancer Progression.

Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma.

Growth hormone-releasing hormone and cancer

Growth hormone and radiation therapy: friend, foe, or both?

The development of growth hormone-releasing hormone analogs: Therapeutic advances in cancer, regenerative medicine, and metabolic disorders

Autocrine Human Growth Hormone Stimulates Oncogenicity of Endometrial Carcinoma Cells.

Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma.

Growth hormone-releasing hormone and its analogues in health and disease

Growth Hormone Receptor Regulation in Cancer and Chronic Diseases

Growth Hormone and Aging: New Findings

Growth and Growth Hormone through the Ages: Art and Science

Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer

Autocrine Human Growth Hormone Stimulates the Tumor Initiating Capacity and Metastasis of Estrogen Receptor-Negative Mammary Carcinoma Cells.

Growth Hormone Receptor Promotes Osteosarcoma Cell Growth and Metastases

Growth Hormone and Aging: Updated Review

Autocrine Hgh Stimulates Oncogenicity, Epithelial-Mesenchymal Transition and Cancer Stem Cell-Like Behavior in Human Colorectal Carcinoma.